PMA
P160014: COBRA PzF NanoCoated Coronary Stent System
FDA PMA · STENT, CORONARY · Celonova Biosciences, Inc.
Key facts
| PMA number | P160014 |
|---|---|
| Trade name | COBRA PzF NanoCoated Coronary Stent System |
| Generic name | STENT, CORONARY |
| Applicant | Celonova Biosciences, Inc. |
| Owner/operator | Seno Medical Instruments, Inc. |
| Product code | MAF |
| Approval date | Feb 21, 2017 |
| Docket number | 17M-1122 |
| Notice date | Feb 17, 2017 |
| Establishment registration | 3014755924 |
| FEI number | 3014755924 |
At a glance
- 10–99 Supplements
- Oct 12, 2021 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- 10–99 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: